Abstract
This study aimed to explore whether cytotoxin-associated gene A (CagA) can inhibit cell cycle progression by activating nuclear factor of activated T cells (NFAT) in lymphoma B cells and contribute to Helicobacter pylori eradication (HPE) responsiveness (complete remission [CR] after HPE) in gastric mucosa-associated lymphoid tissue (MALT) lymphoma. We co-cultured three B-lymphoma cell lines (MA-1, OCI-Ly3, and OCI-Ly7) with HP strains (derived from HPE-responsive gastric MALT lymphoma) and evaluated the expression patterns of CagA, phosphorylated (p)-CagA (CagA), and CagA-signaling molecules, cell-cycle inhibitors, p-NFATc1 (Ser), and NFATc1 using western blotting. Furthermore, we evaluated the association between nuclear NFATc1 expression in the tumor cells of 91 patients who received first-line HPE (59 patients with HPE responsiveness and 32 without HPE responsiveness) and HPE responsiveness and CagA expression in tumor cells. In HP strains co-cultured with B cell lymphoma cell lines, CagA was translocated to the nucleus through tyrosine phosphorylation (CagA) and simultaneously dephosphorylated NFATc1, subsequently causing nuclear NFATc1 translocation and stimulating the expression of p-SHP-2/p-ERK/Bcl-xL. Activated NFATc1 causes G1 cell cycle retardation in both MA-1 and OCI-Ly3 cells by triggering p21 and p27 production. Nuclear NFATc1 localization was significantly associated with the presence of CagA in gastric MALT lymphomas (80% [41/51] vs. 33% [13/40]; p < 0.001) and with HPE responsiveness (73% [43/59] vs. 25% [8/32]; p < 0.001). Patients exhibiting both the presence of CagA and nuclear NFATc1 localization responded more rapidly to HPE than those without (median interval to CR, 4.00 vs. 6.00 months, p = 0.003). Our findings indicated that CagA and NFATc1 cooperatively participate in the lymphomagenesis of HPE-responsive gastric MALT lymphoma.
Overview
- The study aimed to investigate the role of cytotoxin-associated gene A (CagA) in inhibiting cell cycle progression by activating nuclear factor of activated T cells (NFAT) in lymphoma B cells and contributing to Helicobacter pylori eradication (HPE) responsiveness in gastric mucosa-associated lymphoid tissue (MALT) lymphoma. The study used co-culture experiments with three B-lymphoma cell lines and HP strains derived from HPE-responsive gastric MALT lymphoma. The study evaluated the expression patterns of CagA, phosphorylated (p)-CagA (CagA), and CagA-signaling molecules, cell-cycle inhibitors, p-NFATc1 (Ser), and NFATc1 using western blotting. The study also evaluated the association between nuclear NFATc1 expression in the tumor cells of 91 patients who received first-line HPE and HPE responsiveness and CagA expression in tumor cells. The primary objective of the study was to determine the role of CagA and NFATc1 in the lymphomagenesis of HPE-responsive gastric MALT lymphoma and their contribution to HPE responsiveness.
Comparative Analysis & Findings
- The study found that CagA was translocated to the nucleus through tyrosine phosphorylation (CagA) and simultaneously dephosphorylated NFATc1, subsequently causing nuclear NFATc1 translocation and stimulating the expression of p-SHP-2/p-ERK/Bcl-xL. Activated NFATc1 causes G1 cell cycle retardation in both MA-1 and OCI-Ly3 cells by triggering p21 and p27 production. The study also found that nuclear NFATc1 localization was significantly associated with the presence of CagA in gastric MALT lymphomas and with HPE responsiveness. Patients exhibiting both the presence of CagA and nuclear NFATc1 localization responded more rapidly to HPE than those without. These findings suggest that CagA and NFATc1 cooperatively participate in the lymphomagenesis of HPE-responsive gastric MALT lymphoma and contribute to HPE responsiveness.
Implications and Future Directions
- The study's findings have significant implications for the field of research and clinical practice. The study provides insights into the role of CagA and NFATc1 in the lymphomagenesis of HPE-responsive gastric MALT lymphoma and their contribution to HPE responsiveness. The study also identifies potential therapeutic targets for the treatment of gastric MALT lymphoma. Future research could explore the role of CagA and NFATc1 in other types of lymphomas and their contribution to HPE responsiveness. Future research could also investigate the use of CagA and NFATc1 as therapeutic targets for the treatment of gastric MALT lymphoma.